Opinion November 3 DR. MAKARY, DR OZ: People talk about lowering healthcare costs, but the Trump administration is doing it FDA announces major reforms to streamline biosimilar approvals, potentially saving Americans billions on prescription drug costs by removing extra clinical trial requirements.
